Fundraising FoxAlbutec
Rostock, DE · Founded 2004 · 1 known investors
Find your way into Albutec
Sign up to see every warm intro you have to Albutec
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Albutec team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure. The platform is intended for use by doctors, nurses, and critical care medical teams treating liver patients.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Albutec do?
- Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure. The platform is intended for use by doctors, nurses, and critical care medical teams treating liver patients.
- Who are Albutec's investors?
- Albutec's investors include Fresenius Medical Care Ventures.
- Where is Albutec headquartered?
- Albutec is headquartered in Rostock, DE.